Le Lézard
Classified in: Health
Subjects: LAW/LEGAL ISSUES, HEALTH, ANALYSTS' COMMENTS, MISCELLANEOUS, MISCELLANEOUS

New Frontier Data Releases First Comparative Study on EU and US Cannabis Regulations


Washington, July 28, 2021 (GLOBE NEWSWIRE) -- New Frontier Data (https://newfrontierdata.com), the premier data, analytics and technology firm specializing in the global cannabis industry, in partnership with S?RSE Technology, the leader in water-soluble emulsion technology, releases its latest report, 2021 Cannabis Regulatory Landscape: Emerging Trends in North America & Europe, providing an unprecedented analysis of the progression of regulatory oversight in the world's two largest cannabis consumer markets. The report provides an understanding of governmental inconsistencies and regional market dynamics shaping the regulatory landscape, as well as guidance for state and national institutions working to build and maintain a thriving yet complex industry.

This first-of-its-kind comparative assessment concludes that the disparity in evolving regulations at the national and state levels is introducing significant uncertainty, challenges and risk for industry stakeholders globally. It also spotlights the importance of considering consumer sentiment and behavior in the development of regional and global regulation.

"While New Frontier Data has found the overall cannabis regulatory framework to be highly fragmented and nuanced across national and state borders, we expect consumer sentiment and behavior to be the consistent driving force behind regulatory evolution, maturation, and ideally, global standardization or, at the very least, regional standardization," noted Giadha A. DeCarcer, Founder and Executive Chair of New Frontier Data. "Our latest study shows cannabis consumers demand quality standards that align with more mature consumer packaged goods sectors, creating opportunities across compliance, lab testing, packaging, labeling and other ancillary verticals needed to support more rigorous and standardized regulation."

Key Report Findings:

Download a complimentary copy of 2021 Cannabis Regulatory Landscape: Emerging Trends in North America & Europe here: https://info.newfrontierdata.com/2021-cannabis-regulatory-landscape

About New Frontier Data:

New Frontier Data is the premier data, analytics and technology firm specializing in the global cannabis industry, delivering solutions that enable investors, operators, advertisers, brands, researchers, and policy makers to assess, understand, engage, and transact with the cannabis industry and its consumers.

Our mission is to inform policy and commercial activity for the global legal cannabis industry. We maintain a neutral position on the merits of cannabis legalization through comprehensive and transparent data analysis and projections that shape industry trends, dynamics, demand, and opportunity drivers. Founded in 2014, New Frontier Data is headquartered in Washington, D.C. with a presence in Europe, Latin America and Africa. For more information about New Frontier Data, please visit us at www.NewFrontierData.com.

About S?RSE Technology:

S?RSE Technology is a water-soluble emulsion technology designed for product developers to provide consumers with a better cannabis experience with greater bioavailability, near-perfect dosing, shelf-stability, and safe ingredients. Their patent-pending technology converts oil into S?RSE, a proprietary water-soluble emulsion, for seamless integration as an ingredient in food items, beverages, topicals, and medical applications.

Attachment



These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: